S. Holgate
Physiology · Nature Medicine · 2000–2020
A researcher in the Science corpus: 19 papers; trusts 2 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 79 citations into it; #1,252 of 2,276 by trust here, #350 by citations
- Immunology — 43 citations into it
- Pulmonary and Respiratory Medicine — 42 citations into it
- Health, Toxicology and Mutagenesis — 20 citations into it; #531 of 1,398 by trust here, #1,173 by citations
Whom S. Holgate trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Holgate overall
Papers from S. Holgate's perspective
Ordered by how strongly the researchers S. Holgate trusts endorse each paper. Same corpus, a different order for every researcher.
- Evidence of a role of tumor necrosis factor alpha in refractory asthma. (New England Journal of Medicine)
- A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. (American Journal of Respiratory and Critical Care Medicine)
- Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma (Nature reviews. Immunology)
- Fatalities due to anaphylactic reactions to foods. (Journal of Allergy and Clinical Immunology)
- Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. (American Journal of Respiratory and Critical Care Medicine)
- Rhinitis as an independent risk factor for adult-onset asthma. (Journal of Allergy and Clinical Immunology)
- Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. (The Lancet)
- Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. (The Lancet)
- A metalloprotease-disintegrin participating in myoblast fusion
- A call for transparent reporting to optimize the predictive value of preclinical research (Nature)
Their papers
- The ARRIVE guidelines 2.0: updated guidelines for reporting animal research (2020) — 1,289 citations
- Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness (2002) — 1,120 citations
- The airway epithelium: Structural and functional properties in health and disease (2003) — 616 citations
- Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. (2000) — 1,909 citations
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research* (2020) — 7,982 citations
- Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019 (2019) — 761 citations
- Treatable traits: toward precision medicine of chronic airway diseases (2016) — 1,002 citations
- Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. (2013) — 594 citations
- Innate and adaptive immune responses in asthma (2012) — 900 citations
- Defective epithelial barrier function in asthma. (2011) — 638 citations
- Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. (2010) — 759 citations
- Treatment strategies for allergy and asthma (2008) — 718 citations
- Role of deficient type III interferon-λ production in asthma exacerbations (2006) — 916 citations
- Role of deficient type III interferon-lambda production in asthma exacerbations. (2006) — 609 citations
- The role of the mast cell in the pathophysiology of asthma. (2006) — 615 citations
- Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. (2004) — 645 citations
- The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma (2003) — 767 citations
- Mast-cell infiltration of airway smooth muscle in asthma. (2002) — 1,300 citations
- Air pollution and health. (2002) — 621 citations